Page last updated: 2024-10-17

bupropion and Dermatitis Exfoliativa

bupropion has been researched along with Dermatitis Exfoliativa in 2 studies

Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.

Research Excerpts

ExcerptRelevanceReference
" We report three patients with known psoriasis in whom use of bupropion (Zyban), prescribed to assist with cessation of smoking, led to severe pustular or erythrodermic exacerbation of psoriasis within 3-5 weeks."7.71Generalized pustular and erythrodermic psoriasis associated with bupropion treatment. ( Cox, NH; Dodd, H; Gordon, PM, 2002)
" We report three patients with known psoriasis in whom use of bupropion (Zyban), prescribed to assist with cessation of smoking, led to severe pustular or erythrodermic exacerbation of psoriasis within 3-5 weeks."3.71Generalized pustular and erythrodermic psoriasis associated with bupropion treatment. ( Cox, NH; Dodd, H; Gordon, PM, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matos-Pires, E1
Campos, S1
Mendes-Bastos, P1
João, A1
Fernandes, C1
Cox, NH1
Gordon, PM1
Dodd, H1

Other Studies

2 other studies available for bupropion and Dermatitis Exfoliativa

ArticleYear
Erythrodermic psoriasis induced by bupropion.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2017, Volume: 31, Issue:2

    Topics: Adult; Bupropion; Dermatitis, Exfoliative; Humans; Male; Nicotinic Antagonists; Psoriasis; Smoking C

2017
Generalized pustular and erythrodermic psoriasis associated with bupropion treatment.
    The British journal of dermatology, 2002, Volume: 146, Issue:6

    Topics: Adult; Bupropion; Dermatitis, Exfoliative; Dopamine Uptake Inhibitors; Drug Eruptions; Female; Human

2002